Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$145.54 - $178.83 $1.91 Million - $2.34 Million
13,103 Added 129.53%
23,219 $4.03 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $1.68 Million - $2.02 Million
10,116 New
10,116 $1.71 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $696,138 - $802,887
4,165 New
4,165 $724,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $234,422 - $300,735
-1,503 Reduced 47.29%
1,675 $288,000
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $576,457 - $743,747
3,178 New
3,178 $599,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.